Lukas C. Kapitein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lukas C. Kapitein has a total of 451 co-authors. Here are the top co-authors by number of shared publications:
- Casper C. Hoogenraad
Department of Neuroscience, Genentech, Inc., South San Francisco, CA 94080, USA
23 shared publications - Anna Akhmanova
Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University, Utrecht, the Netherlands
21 shared publications Eugene A. Katrukha
Utrecht University
13 shared publicationsWilco Nijenhuis
Cell Biology, Neurobiology and Biophysics, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands
9 shared publicationsRoderick P. Tas
Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands
7 shared publications- Wilco Nijenhuis
Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University
7 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (11) , 2219-2230
Taxane-induced conformational changes in the microtubule lattice activate GEF-H1-dependent RhoA signalling
Taxanes are widely used chemotherapeutic agents that perturb cell division. They also exert effects during interphase, but the underlying mechanisms are poorly understood. Here we show that taxanes activate RhoA signalling and induce actin remodelling by releasing the RhoA activator GEF-H1 from microtubules. This taxane-induced release of GEF-H1 occurs rapidly, is independent of tubulin post-translational modifications, and can be recapitulated using purified proteins. In vitro reconstitution assays combined with analyses of microtubule structure revealed that microtubule binding by GEF-H1 is inhibited by microtubule-stabilizing ligands that expand the microtubule lattice, such as taxanes and GMPCPP, but not by others, including GTPγS and discodermolide, which stabilize a compacted microtubule lattice. Our findings demonstrate that alterations in microtubule lattice conformation can activate key signalling pathways, offering insights into the mode of action of taxanes and the possible origins of their side effects.
- 24 September 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (11) , 2219-2230
Open AccessTaxane-induced conformational changes in the microtubule lattice activate GEF-H1-dependent RhoA signalling
Taxanes are widely used chemotherapeutic agents that perturb cell division. They also exert effects during interphase, but the underlying mechanisms are poorly understood. Here we show that taxanes activate RhoA signalling and induce actin remodelling by releasing the RhoA activator GEF-H1 from microtubules. This taxane-induced release of GEF-H1 occurs rapidly, is independent of tubulin post-translational modifications, and can be recapitulated using purified proteins. In vitro reconstitution assays combined with analyses of microtubule structure revealed that microtubule binding by GEF-H1 is inhibited by microtubule-stabilizing ligands that expand the microtubule lattice, such as taxanes and GMPCPP, but not by others, including GTPγS and discodermolide, which stabilize a compacted microtubule lattice. Our findings demonstrate that alterations in microtubule lattice conformation can activate key signalling pathways, offering insights into the mode of action of taxanes and the possible origins of their side effects.
- 7 September 2026
- Published by Elsevier in Current Biology
- Vol. 36 (17) , R953-R955
Neuronal polarity: Opposing actin networks drive transient polarization
- 7 September 2026
- Published by Elsevier in Current Biology
- Vol. 36 (17) , R953-R955
Neuronal polarity: Opposing actin networks drive transient polarization
- Open Access
- 10 August 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (60) , e74563
Spatial Control of Light‐Responsive Proteins and Optogenetics Within Hydrogels via Volumetric Bioprinting
Spatiotemporal control over cell fate and behavior within bioprinted constructs remains a key challenge in tissue engineering. Optogenetics offers versatile potential for non‐invasive regulation of biological processes. Yet, its integration within large‐scale, cell‐laden bioprinted materials is still limited, especially considering the spatial constraints of existing light delivery methods. In this study, we introduce a novel approach that repurposes tomographic volumetric bioprinting to enable post‐printing stimulation of photosensitive protein‐switches and optogenetic circuits in cells deep within hydrogel constructs. By converging different bioprinting approaches, computer vision, context‐aware model generation, and synthetic biology and cell engineering, we demonstrated selective activation of a fluorescent, light‐responsive protein probe within multi‐material centimeter‐scale constructs. Moreover, leveraging a multi‐wavelength volumetric bioprinter, we further demonstrate this concept by selectively stimulating cells expressing a near‐infrared optogenetic system that triggers gene expression and the induction of pancreas‐specific transcription factors. The described methods provide platforms for remote, repeatable, and localized control of biological events in volumetric constructs, opening new possibilities for advanced tissue models, and dynamic tuning of cell‐mediated protein production in engineered living systems.
- 10 August 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (60) , e74563
Open AccessSpatial Control of Light‐Responsive Proteins and Optogenetics Within Hydrogels via Volumetric Bioprinting
Spatiotemporal control over cell fate and behavior within bioprinted constructs remains a key challenge in tissue engineering. Optogenetics offers versatile potential for non‐invasive regulation of biological processes. Yet, its integration within large‐scale, cell‐laden bioprinted materials is still limited, especially considering the spatial constraints of existing light delivery methods. In this study, we introduce a novel approach that repurposes tomographic volumetric bioprinting to enable post‐printing stimulation of photosensitive protein‐switches and optogenetic circuits in cells deep within hydrogel constructs. By converging different bioprinting approaches, computer vision, context‐aware model generation, and synthetic biology and cell engineering, we demonstrated selective activation of a fluorescent, light‐responsive protein probe within multi‐material centimeter‐scale constructs. Moreover, leveraging a multi‐wavelength volumetric bioprinter, we further demonstrate this concept by selectively stimulating cells expressing a near‐infrared optogenetic system that triggers gene expression and the induction of pancreas‐specific transcription factors. The described methods provide platforms for remote, repeatable, and localized control of biological events in volumetric constructs, opening new possibilities for advanced tissue models, and dynamic tuning of cell‐mediated protein production in engineered living systems.
- Open Access
Rapid removal of nuclear aggregates via proteasome- and VCP-dependent disaggregation
Cells use multiple protein quality control (PQC) mechanisms to counteract the toxic effects of protein aggregation caused by cellular stress, ageing or disease. While it is known that PQC mechanisms differ between cellular compartments, studying such differences has remained challenging. Previously, we developed an assay to study cytosolic PQC using aggregates formed through chemically-induced dimerization (termed PIMs, particles induced by multimerization). Here, we introduce nuclear PIMs as a tool to study nuclear quality control. Using high-resolution and high-throughput imaging, we show that nuclear aggregate removal depends on the proteasome and the unfoldase VCP, but not on Hsp70. Strikingly, following dissolution many PIM subunits were exported to the cytosol via exportin-1-dependent shuttling, indicating that disaggregation and resolubilization dominated over degradation. Proteasomal disaggregation was confirmed using live-cell turnover experiments. Together, these findings reveal a mechanism in which the proteasome and VCP disaggregate, rather than degrade, nuclear protein aggregates, with the resulting subunits subsequently cleared via cytosolic aggrephagy.
Open AccessRapid removal of nuclear aggregates via proteasome- and VCP-dependent disaggregation
Cells use multiple protein quality control (PQC) mechanisms to counteract the toxic effects of protein aggregation caused by cellular stress, ageing or disease. While it is known that PQC mechanisms differ between cellular compartments, studying such differences has remained challenging. Previously, we developed an assay to study cytosolic PQC using aggregates formed through chemically-induced dimerization (termed PIMs, particles induced by multimerization). Here, we introduce nuclear PIMs as a tool to study nuclear quality control. Using high-resolution and high-throughput imaging, we show that nuclear aggregate removal depends on the proteasome and the unfoldase VCP, but not on Hsp70. Strikingly, following dissolution many PIM subunits were exported to the cytosol via exportin-1-dependent shuttling, indicating that disaggregation and resolubilization dominated over degradation. Proteasomal disaggregation was confirmed using live-cell turnover experiments. Together, these findings reveal a mechanism in which the proteasome and VCP disaggregate, rather than degrade, nuclear protein aggregates, with the resulting subunits subsequently cleared via cytosolic aggrephagy.
- Open Access
System Identification and Control for Optogenetics in Mammalian Nucleocytoplasmic Transport
Optogenetics enables experiments in out-of-equilibrium conditions to clarify biological mechanisms and quantify biophysical parameters. However, modelling and control techniques to study mammalian cell biology under optogenetic perturbation remain underutilised. Here, we benchmark these methods within mammalian cells by steering nucleocytoplasmic transport via the optogenetic LEXY protein in outcome-driven microscopy. First, we employ system identification to obtain models that predict transport dynamics by minimising the prediction error. We quantify this prediction accuracy for one biophysical model and two black-box models. Second, we evaluate closed-loop control efficacy by steering transport along a predefined trajectory using model-free Proportional Integral (PI) control, model-based Linear Quadratic Regulation (LQR) and Model Predictive Control (MPC). Both the predictive models and the applied control techniques demonstrate robust performance against cell-to-cell variation. This biological variation is quantified by the parameter distributions obtained from model identification with single-cell trajectories. While we show that model-free techniques such as PI and gain-scheduled PI achieve steering without explict model knowledge, predictive architectures offer better performance under this cell-to-cell variation and time-varying setpoints. Moreover, black-box predictive accuracy suggests that this model-based control is possible, even when explicit mechanistic understanding is missing. Ultimately, we demonstrate that predictive modelling and optogenetics enable quantitative characterisation and precise manipulation of mammalian cells, while offering practical guidelines for the implementation of these techniques.
Open AccessSystem Identification and Control for Optogenetics in Mammalian Nucleocytoplasmic Transport
Optogenetics enables experiments in out-of-equilibrium conditions to clarify biological mechanisms and quantify biophysical parameters. However, modelling and control techniques to study mammalian cell biology under optogenetic perturbation remain underutilised. Here, we benchmark these methods within mammalian cells by steering nucleocytoplasmic transport via the optogenetic LEXY protein in outcome-driven microscopy. First, we employ system identification to obtain models that predict transport dynamics by minimising the prediction error. We quantify this prediction accuracy for one biophysical model and two black-box models. Second, we evaluate closed-loop control efficacy by steering transport along a predefined trajectory using model-free Proportional Integral (PI) control, model-based Linear Quadratic Regulation (LQR) and Model Predictive Control (MPC). Both the predictive models and the applied control techniques demonstrate robust performance against cell-to-cell variation. This biological variation is quantified by the parameter distributions obtained from model identification with single-cell trajectories. While we show that model-free techniques such as PI and gain-scheduled PI achieve steering without explict model knowledge, predictive architectures offer better performance under this cell-to-cell variation and time-varying setpoints. Moreover, black-box predictive accuracy suggests that this model-based control is possible, even when explicit mechanistic understanding is missing. Ultimately, we demonstrate that predictive modelling and optogenetics enable quantitative characterisation and precise manipulation of mammalian cells, while offering practical guidelines for the implementation of these techniques.
- Open Access
Calsyntenin-1 and calsyntenin-3 coordinate TGN exit of axonal cargoes
Neurons rely on precise biosynthetic protein transport from the soma to the axon and dendrites. Brain-enriched calsyntenins (CSTN1–3) are unique transmembrane adaptors that link cargo to kinesin-1 for transport. Yet, the neuronal distribution and interdependence of the three CSTN paralogs remain unclear. Here, we dissected their subcellular localization and contribution to biosynthetic protein transport. CSTN paralogs were predominantly localized to the TGN and axonal vesicles, with CSTN1 and CSTN3 showing higher expression levels than CSTN2. Depletion of either CSTN1 or CSTN3 affected axonal abundance of the other, suggesting that they function within the same pathway. Consistently, knockdown of CSTN1 or CSTN3, but not CSTN2, impaired the TGN exit and transport of multiple biosynthetic cargoes to the axon. Interestingly, most CSTN-positive vesicles exiting the TGN and in the axon were marked by the biosynthetic trafficking regulator RAB6A. Furthermore, we identified opposing, paralog-specific roles of CSTN1 and CSTN3 in regulating RAB6A levels at the TGN, thereby contributing to Golgi organization and axonal trafficking. Loss of CSTN1 reduced RAB6A and induced Golgi compaction, whereas loss of CSTN3 increased RAB6A and promoted Golgi dispersal. Together, we reveal that CSTN1 and CSTN3 have distinct, yet intersecting roles in the regulation of biosynthetic axonal transport.
Open AccessCalsyntenin-1 and calsyntenin-3 coordinate TGN exit of axonal cargoes
Neurons rely on precise biosynthetic protein transport from the soma to the axon and dendrites. Brain-enriched calsyntenins (CSTN1–3) are unique transmembrane adaptors that link cargo to kinesin-1 for transport. Yet, the neuronal distribution and interdependence of the three CSTN paralogs remain unclear. Here, we dissected their subcellular localization and contribution to biosynthetic protein transport. CSTN paralogs were predominantly localized to the TGN and axonal vesicles, with CSTN1 and CSTN3 showing higher expression levels than CSTN2. Depletion of either CSTN1 or CSTN3 affected axonal abundance of the other, suggesting that they function within the same pathway. Consistently, knockdown of CSTN1 or CSTN3, but not CSTN2, impaired the TGN exit and transport of multiple biosynthetic cargoes to the axon. Interestingly, most CSTN-positive vesicles exiting the TGN and in the axon were marked by the biosynthetic trafficking regulator RAB6A. Furthermore, we identified opposing, paralog-specific roles of CSTN1 and CSTN3 in regulating RAB6A levels at the TGN, thereby contributing to Golgi organization and axonal trafficking. Loss of CSTN1 reduced RAB6A and induced Golgi compaction, whereas loss of CSTN3 increased RAB6A and promoted Golgi dispersal. Together, we reveal that CSTN1 and CSTN3 have distinct, yet intersecting roles in the regulation of biosynthetic axonal transport.
- Open Access
Engineered microRNA feedback circuits enable tunable and autonomous control of synthetic receptor activity
Synthetic receptors are powerful tools for cellular engineering, yet their utility is often constrained by constitutive activity and the absence of natural feedback mechanisms that maintain cellular homeostasis. To address this, we engineered an autonomous regulatory circuit for synthetic Notch (synNotch) receptor activation using an orthogonal microRNA (miRNA)-mediated negative feedback mechanism in mammalian cells. Specifically, synNotch activation induces the expression of a synthetic miRNA that targets complementary sites engineered into the synNotch transcript, resulting in a self-limiting feedback loop. We demonstrate that synNotch repression positively correlates with the number of miRNA target sites integrated into the receptor transcript, enabling tunable control of receptor expression. Furthermore, flow cytometry and live-cell imaging analyses revealed effective suppression of synNotch expression following activation. Downstream target gene expression peaked at approximately 48 hours post-activation before gradually declining as the feedback circuit engaged. This approach achieves autonomous synthetic receptor regulation—eliminating the need for external intervention—and enables tunable response dynamics through rational circuit design. Our miRNA feedback strategy provides a generalizable platform for engineering self-regulating synthetic receptor systems with improved control and predictability for cellular engineering applications.
Open AccessEngineered microRNA feedback circuits enable tunable and autonomous control of synthetic receptor activity
Synthetic receptors are powerful tools for cellular engineering, yet their utility is often constrained by constitutive activity and the absence of natural feedback mechanisms that maintain cellular homeostasis. To address this, we engineered an autonomous regulatory circuit for synthetic Notch (synNotch) receptor activation using an orthogonal microRNA (miRNA)-mediated negative feedback mechanism in mammalian cells. Specifically, synNotch activation induces the expression of a synthetic miRNA that targets complementary sites engineered into the synNotch transcript, resulting in a self-limiting feedback loop. We demonstrate that synNotch repression positively correlates with the number of miRNA target sites integrated into the receptor transcript, enabling tunable control of receptor expression. Furthermore, flow cytometry and live-cell imaging analyses revealed effective suppression of synNotch expression following activation. Downstream target gene expression peaked at approximately 48 hours post-activation before gradually declining as the feedback circuit engaged. This approach achieves autonomous synthetic receptor regulation—eliminating the need for external intervention—and enables tunable response dynamics through rational circuit design. Our miRNA feedback strategy provides a generalizable platform for engineering self-regulating synthetic receptor systems with improved control and predictability for cellular engineering applications.
- Open Access
Fasting reverses PLN R14del-mediated cardiomyopathy through lysosomal reactivation
Genetic cardiomyopathies consist of a heterogeneous group of myocardial disorders caused by variants that disrupt key regulators of cardiac structure and function. Variants in PLN, encoding phospholamban (PLN), the main inhibitor of the sarco/endoplasmic reticulum Ca²⁺-ATPase 2a (SERCA2a), have been linked to both dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM). Among these, the PLN Arg14del (R14del) variant is the most prevalent. PLN R14del cardiomyopathy is characterized by the accumulation of large perinuclear PLN aggregates in cardiomyocytes of end-stage heart failure tissue. However, the mechanisms driving PLN aggregate formation and their role in disease progression remain unresolved. Using a humanized plna R14del zebrafish model, left ventricular tissue from end-stage PLN R14del cardiomyopathy patients and pharmacological modeling in wild type (WT) cardiac slices, we demonstrate that previously described PLN aggregates represent accumulated sarcoplasmic reticulum (SR)-derived PLN-containing vesicles that form due to impaired SERCA2a activity and increased cytosolic Ca²⁺ levels. Furthermore, these SR-derived vesicles often localize adjacent to lysosomes. Interestingly, Ca 2+ dysregulation in plna R14del hearts leads to reduced lysosomal function, resulting in SR-derived vesicle accumulation at the microtubule organizing center (MTOC). This perinuclear accumulation induces microtubule aster formation and subsequent cellular disorganization, including sarcomere misalignment and nuclear deformation. Strikingly, reactivation of lysosomal function through fasting reduces SR-derived vesicle accumulation, restores microtubule integrity, and rescues cellular organization in plna R14del zebrafish hearts. Together, these findings identify impaired lysosomal clearance of SR-derived vesicles and the resulting microtubule disorganization as key pathological mechanisms driving PLN R14del cardiomyopathy. Additionally, our results highlight lysosomal reactivation as a promising potential therapeutic strategy to halt or reverse PLN R14del cardiomyopathy progression. Main findings: PLN aggregates in PLN R14del cardiomyopathy represent SR-derived vesicles formed due to Ca²⁺ dysregulation. These SR-derived vesicles often localize perinuclearly at the microtubule organizing center (MTOC), where they are positioned adjacent to lysosomes. Ca 2+ dysregulation leads to lysosomal dysfunction which drives vesicle accumulation responsible for microtubule remodeling and pathological cellular rearrangements. Lysosomal reactivation restores vesicle clearance and rescues cardiomyocyte structure.
Open AccessFasting reverses PLN R14del-mediated cardiomyopathy through lysosomal reactivation
Genetic cardiomyopathies consist of a heterogeneous group of myocardial disorders caused by variants that disrupt key regulators of cardiac structure and function. Variants in PLN, encoding phospholamban (PLN), the main inhibitor of the sarco/endoplasmic reticulum Ca²⁺-ATPase 2a (SERCA2a), have been linked to both dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM). Among these, the PLN Arg14del (R14del) variant is the most prevalent. PLN R14del cardiomyopathy is characterized by the accumulation of large perinuclear PLN aggregates in cardiomyocytes of end-stage heart failure tissue. However, the mechanisms driving PLN aggregate formation and their role in disease progression remain unresolved. Using a humanized plna R14del zebrafish model, left ventricular tissue from end-stage PLN R14del cardiomyopathy patients and pharmacological modeling in wild type (WT) cardiac slices, we demonstrate that previously described PLN aggregates represent accumulated sarcoplasmic reticulum (SR)-derived PLN-containing vesicles that form due to impaired SERCA2a activity and increased cytosolic Ca²⁺ levels. Furthermore, these SR-derived vesicles often localize adjacent to lysosomes. Interestingly, Ca 2+ dysregulation in plna R14del hearts leads to reduced lysosomal function, resulting in SR-derived vesicle accumulation at the microtubule organizing center (MTOC). This perinuclear accumulation induces microtubule aster formation and subsequent cellular disorganization, including sarcomere misalignment and nuclear deformation. Strikingly, reactivation of lysosomal function through fasting reduces SR-derived vesicle accumulation, restores microtubule integrity, and rescues cellular organization in plna R14del zebrafish hearts. Together, these findings identify impaired lysosomal clearance of SR-derived vesicles and the resulting microtubule disorganization as key pathological mechanisms driving PLN R14del cardiomyopathy. Additionally, our results highlight lysosomal reactivation as a promising potential therapeutic strategy to halt or reverse PLN R14del cardiomyopathy progression. Main findings: PLN aggregates in PLN R14del cardiomyopathy represent SR-derived vesicles formed due to Ca²⁺ dysregulation. These SR-derived vesicles often localize perinuclearly at the microtubule organizing center (MTOC), where they are positioned adjacent to lysosomes. Ca 2+ dysregulation leads to lysosomal dysfunction which drives vesicle accumulation responsible for microtubule remodeling and pathological cellular rearrangements. Lysosomal reactivation restores vesicle clearance and rescues cardiomyocyte structure.
- Open Access
- 20 March 2026
- Published by Walter de Gruyter GmbH in Methods in Microscopy
- Vol. 3 (3) , 219-231
Beyond 4×: pathways to higher expansion factors in expansion microscopy
Expansion microscopy (ExM) enables nanoscale imaging with conventional light microscopes by physically magnifying biological specimens. While classical ExM achieves ∼4× linear expansion, advances in polymer chemistry and workflow design now routinely push expansion factors beyond 4×, thereby improving resolution while retaining compatibility with diverse labelling strategies. Here, we review current one-step and multi-step (iterative) high-expansion approaches, outlining how modifications to monomer composition yield highly swellable gels, and how iterative embedding can bypass the mechanical limits of any single polymer network. Finally, we discuss practical considerations and highlight how emerging strategies could maximise swelling capacity and simplify workflows. Together, these developments move the field toward scalable, reproducible, and broadly accessible nanoscale imaging.
- 20 March 2026
- Published by Walter de Gruyter GmbH in Methods in Microscopy
- Vol. 3 (3) , 219-231
Open AccessBeyond 4×: pathways to higher expansion factors in expansion microscopy
Expansion microscopy (ExM) enables nanoscale imaging with conventional light microscopes by physically magnifying biological specimens. While classical ExM achieves ∼4× linear expansion, advances in polymer chemistry and workflow design now routinely push expansion factors beyond 4×, thereby improving resolution while retaining compatibility with diverse labelling strategies. Here, we review current one-step and multi-step (iterative) high-expansion approaches, outlining how modifications to monomer composition yield highly swellable gels, and how iterative embedding can bypass the mechanical limits of any single polymer network. Finally, we discuss practical considerations and highlight how emerging strategies could maximise swelling capacity and simplify workflows. Together, these developments move the field toward scalable, reproducible, and broadly accessible nanoscale imaging.
- Open Access
- 3 March 2026
- Published by Springer Nature in npj Imaging
- Vol. 4 (1) , 14
Smart microscopy: adaptive microscope control to improve the way we see life
Smart microscopy lies at the intersection of biology, optics, engineering, and computer science. Unlike traditional microscopes, smart systems actively adapt their acquisition settings in real time based on information extracted from the sample, allowing experiments to navigate competing demands such as resolution, speed and sample health. In this review, we present a practical framework for what makes a microscope “smart,” defining smart microscopy as the combination of real-time analysis, feedback control, and automated actuation. To guide implementation, we classify smart microscopy approaches by experimental goal (quality-, event-, target-, information- or outcome-driven) and discuss the corresponding strategies for analysis and control. Finally, we highlight key challenges and the growing role of community-driven efforts in making smart microscopy more accessible and widely adopted across the life sciences.
- 3 March 2026
- Published by Springer Nature in npj Imaging
- Vol. 4 (1) , 14
Open AccessSmart microscopy: adaptive microscope control to improve the way we see life
Smart microscopy lies at the intersection of biology, optics, engineering, and computer science. Unlike traditional microscopes, smart systems actively adapt their acquisition settings in real time based on information extracted from the sample, allowing experiments to navigate competing demands such as resolution, speed and sample health. In this review, we present a practical framework for what makes a microscope “smart,” defining smart microscopy as the combination of real-time analysis, feedback control, and automated actuation. To guide implementation, we classify smart microscopy approaches by experimental goal (quality-, event-, target-, information- or outcome-driven) and discuss the corresponding strategies for analysis and control. Finally, we highlight key challenges and the growing role of community-driven efforts in making smart microscopy more accessible and widely adopted across the life sciences.